drugset / Trial / NCT04118829
Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Perampanel is a drug used to treat patients with epilepsy/seizures. This study is designed to determine how much perampanel actually crosses the blood brain barrier into the cerebral spinal fluid when the drug is taken.
Timeline
- Start
- 2019-11-01
- Primary completion
- 2022-09
- Completion
- 2023-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perampanel | Small molecule | 4 mg | — |
| Subject | Perampanel | Small molecule | 12 mg | — |